Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Debt / NOTE 0.750% 6/1
-
Market price (% of par)
-
100.29%
-
Total 13F principal
-
$199,988,894
-
Principal change
-
+$25,797,462
-
Total reported market value
-
$201,130,923
-
Number of holders
-
20
-
Value change
-
+$25,329,095
-
Number of buys
-
8
-
Number of sells
-
11
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 0.750% 6/1 as of Q1 2023
As of 31 Mar 2023,
IRONWOOD PHARMACEUTICALS INC - NOTE 0.750% 6/1 was held by
20 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$199,988,894
in principal (par value) of the bond.
The largest 10 bondholders included
CITADEL ADVISORS LLC, CAPSTONE INVESTMENT ADVISORS, LLC, Wellesley Asset Management, TENOR CAPITAL MANAGEMENT Co., L.P., WOLVERINE ASSET MANAGEMENT LLC, Calamos Advisors LLC, SHENKMAN CAPITAL MANAGEMENT INC, III Capital Management, Nuveen Asset Management, LLC, and ABSOLUTE INVESTMENT ADVISERS, LLC.
This page lists
20
institutional bondholders reporting positions
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.